US20200222245A1 - Cranial cap dressing - Google Patents
Cranial cap dressing Download PDFInfo
- Publication number
- US20200222245A1 US20200222245A1 US16/798,707 US202016798707A US2020222245A1 US 20200222245 A1 US20200222245 A1 US 20200222245A1 US 202016798707 A US202016798707 A US 202016798707A US 2020222245 A1 US2020222245 A1 US 2020222245A1
- Authority
- US
- United States
- Prior art keywords
- cranial cap
- dressing
- cap dressing
- cranial
- inner layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000007428 craniotomy Methods 0.000 claims abstract description 24
- 239000002250 absorbent Substances 0.000 claims abstract description 17
- 230000002745 absorbent Effects 0.000 claims abstract description 17
- 239000000463 material Substances 0.000 claims description 16
- 229920000642 polymer Polymers 0.000 claims description 13
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 10
- 239000004599 antimicrobial Substances 0.000 claims description 8
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 239000004332 silver Substances 0.000 claims description 6
- 229910052709 silver Inorganic materials 0.000 claims description 6
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 6
- 239000000853 adhesive Substances 0.000 claims description 5
- 230000001070 adhesive effect Effects 0.000 claims description 5
- 210000001124 body fluid Anatomy 0.000 claims description 4
- 239000004744 fabric Substances 0.000 claims description 4
- 230000003068 static effect Effects 0.000 claims description 4
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 3
- 229960003600 silver sulfadiazine Drugs 0.000 claims description 3
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 claims description 3
- 210000005069 ears Anatomy 0.000 claims description 2
- 210000003128 head Anatomy 0.000 description 12
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 11
- 206010052428 Wound Diseases 0.000 description 11
- 208000027418 Wounds and injury Diseases 0.000 description 11
- 238000000034 method Methods 0.000 description 6
- 241000746998 Tragus Species 0.000 description 5
- 210000000216 zygoma Anatomy 0.000 description 5
- 230000002123 temporal effect Effects 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- 229920001410 Microfiber Polymers 0.000 description 2
- 241000590419 Polygonia interrogationis Species 0.000 description 2
- 229920002334 Spandex Polymers 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 208000012759 altered mental status Diseases 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000004177 elastic tissue Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 210000001595 mastoid Anatomy 0.000 description 2
- 239000003658 microfiber Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000004759 spandex Substances 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000208202 Linaceae Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 229920000433 Lyocell Polymers 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 101150097977 arch-1 gene Proteins 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000004790 ingeo Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000002803 maceration Methods 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/12—Bandages or dressings; Absorbent pads specially adapted for the head or neck
-
- A61F13/00029—
-
- A61F13/00042—
-
- A61F13/00046—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01021—Non-adhesive bandages or dressings characterised by the structure of the dressing
- A61F13/01029—Non-adhesive bandages or dressings characterised by the structure of the dressing made of multiple layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01034—Non-adhesive bandages or dressings characterised by a property
- A61F13/01042—Absorbency
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01034—Non-adhesive bandages or dressings characterised by a property
- A61F13/01046—Air-vapor permeability
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00217—Wound bandages not adhering to the wound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00246—Wound bandages in a special way pervious to air or vapours
- A61F2013/00251—Wound bandages in a special way pervious to air or vapours with macroscopic openings
Definitions
- the present invention relates generally to surgical dressing and specifically to a cranial cap dressing.
- Another object of the present invention is to provide a sterile cranial cap dressing with draw strings to provide a sterile barrier over the surgical site.
- a further object of the present invention is to reduce the infection rate post craniotomy.
- Yet another object of the present invention is to secure placement of craniotomy surgical dressing.
- a still further object of the present invention is to increase the speed and accuracy in which craniotomy surgical dressing is applied.
- the present invention also relates to a cranial cap dressing for dressing a craniotomy wound comprising a breathable elastic outer layer sized to fit snuggly on a human head of a patient and an absorbent inner layer attached to the breathable elastic outer layer.
- the present invention relates to methods of dressing a craniotomy and cranial cap dressings for dressing a human craniotomy wound comprising a breathable elastic outer layer sized to fit snuggly on a head of a human patient, and an absorbent inner layer attached to the breathable elastic outer layer.
- An optional further embodiment includes a plurality of breathing channels in the absorbent inner layer providing a passageway for air through the absorbent inner layer to the breathable elastic outer layer.
- An optional further embodiment includes a contact film polymer layer coating on a proximal skin facing surface of the inner layer that reduces the adhesion of the inner layer to the wound.
- An optional further embodiment includes a plurality of perforations in the contact film polymer layer coating to allow air and bodily fluids to pass through the contact film polymer layer coating.
- An optional further embodiment includes a mechanical fastener along a circumference of the cranial cap dressing, which helps secure the cranial cap dressing on the head of the patient.
- An optional further embodiment includes the mechanical fastener being one of a Velcro flap, a button, a snap, a latch, a buckle, a fabric tie, and a string tie.
- An optional further embodiment includes the mechanical fastener being located at an inferior posterior most portion of the cranial cap dressing.
- An optional further embodiment includes the mechanical fastener being a string tie and further comprising a string substantially further comprising a substantially non-elastic string extending in a channel around the circumference of the cranial cap dressing.
- An optional further embodiment includes an anti-microbial agent being affixed to a proximal surface of the inner layer.
- An optional further embodiment includes the antimicrobial agent being one of elemental or ionic silver.
- An optional further embodiment includes the antimicrobial agent being one of silver nitrate and silver sulfadiazine.
- An optional further embodiment includes the breathable elastic outer layer having a coefficient of static friction between two pieces of the same material being less than 0.3.
- An optional further embodiment includes a proximate breathable layer attached to the inner layer, opposite to the outer layer.
- An optional further embodiment includes a maximum thickness of the inner layer being greater in an area corresponding to an incision than a maximum thickness of the inner layer in an area spaced from the area corresponding to the incision.
- An optional further embodiment includes the inner layer being formed as a checkered pattern of absorbent material lining a proximal skin facing surface of the outer layer.
- An optional further embodiment includes the inner layer being a substantially a continuous layer of absorbent material extending substantially completely across a proximal skin facing surface of the outer layer.
- An optional further embodiment includes a plurality of perforations through the inner layer to provide breathing channels for vapor to pass through the inner layer to the outer layer.
- An optional further embodiment includes a medical adhesive or gel affixed to a circumference of the cranial cap dressing to help releasably secure the cranial cap dressing to a skin of the patient.
- An optional further embodiment includes the cranial cap dressing substantially completely covering a cranium of the patient.
- An optional further embodiment includes one or more flap that may be folded down to cover incisions that extend below a circumference of the cranial cap dressing.
- FIG. 1 is a drawing of a human patient with the cranium location indicated;
- FIG. 2 is a diagrammatic representation of the cranial cap dressing according to the present invention, with the cranial cap dressing represented as hatched lines to allow context of the cranial cap dressing's placement;
- FIG. 3 is a diagrammatic representation of the inner lining of a first embodiment of the cranial cap dressing of FIG. 2 in the area indicated F 3 /F 4 ;
- FIG. 4 is a diagrammatic representation of the inner lining of a second embodiment of the cranial cap dressing analogous with the area indicated F 3 /F 4 in FIG. 2 ;
- FIG. 5 is a diagrammatic representation of a cross section of FIG. 3 along the view indicated as F 5 ;
- FIG. 6 is a diagrammatic representation of a further embodiment of the cranial cap dressing according to the present invention, with the cranial cap dressing represented as hatched lines to allow context of the cranial cap dressing's placement.
- components A, B, and C can consist of (i.e., contain only) components A, B, and C, or can contain not only components A, B, and C but also one or more other components.
- the defined steps can be carried out in any order or simultaneously (except where the context excludes that possibility), and the method can include one or more other steps which are carried out before any of the defined steps, between two of the defined steps, or after all the defined steps (except where the context excludes that possibility).
- the term “at least” followed by a number is used herein to denote the start of a range beginning with that number (which may be a range having an upper limit or no upper limit, depending on the variable being defined). For example “at least 1” means 1 or more than 1.
- the term “at most” followed by a number is used herein to denote the end of a range ending with that number (which may be a range having 1 or 0 as its lower limit, or a range having no lower limit, depending upon the variable being defined). For example, “at most 4” means 4 or less than 4, and “at most 40% means 40% or less than 40%.
- a range is given as “(a first number) to (a second number)” or “(a first number)-(a second number),” this means a range whose lower limit is the first number and whose upper limit is the second number.
- 25 to 100 mm means a range whose lower limit is 25 mm, and whose upper limit is 100 mm.
- the cranial cap dressing 2 comprises and an outer layer 4 and an inner layer 6 .
- the outer layer 6 is preferably stretchable and breathable and allows application of the cranial cap dressing 2 to at least a variety of head 8 sizes for different patients.
- the outer layer 4 can be comprised of normal and/or microfiber designs of synthetic and/or natural fiber alone or in a blend with each other and/or an additional elastic fiber elastic element 34 .
- the synthetic fibers include polyester, nylon, rayon, acetate, ingeo, lyocell, olefin, and polylactide, for example.
- the natural fibers include cotton and flax, for example.
- the elastic fibers can include spandex, for example.
- the outer layer 4 material should be porous enough to provide breathability or ready vapor passage 10 to avoid excessive sweating while wearing the cranial cap dressing 2 . Excessive sweat can lead to periwound maceration among other issues.
- the outer layer 4 while preferably elastic, is not meant to apply physiologically significant compressive force on the patient's head 8 , which would be counterproductive for wound 12 healing.
- the elasticity is meant to be sufficient to fit a variety of head 8 sizes and to snuggly fit onto a patient's head 8 and remain in place without any additional binding. It is anticipated that four sizes of cranial cap dressings 2 will be sufficient for most of the population, from smallest to largest: being pediatric, teen, small adult, large adult.
- the outer layer 4 is designed to preferably not restrict or cut off blood circulation to the patient's head 8 .
- the outer layer 4 is physical barrier protecting the wound 12 from the patient purposely or inadvertently picking at or disturbing the wound site 12 .
- the outer layer 4 also provides scaffolding for the inner layer 6 bandage 14 , holding the inner layer 6 in place on the surface 16 of the patient's head 8 .
- the outer layer 4 can be of uniform elasticity and thickness, or it could have increased elasticity and/or thickness especially adjacent to the perimeter edges of the cranial cap dressing 2 , to increase the chances that the cranial cap dressing 2 will stay in place as the patient moves in bed.
- the inner layer 6 would be preferably comprised of an adsorbent material that allows for fluid absorption, such as blood, sweat and other body fluids, keeping the skin 16 and surgical site 12 appropriately dry.
- the inner layer 4 material may be cotton or cotton based, or other natural or synthetic adsorbent material.
- the inner layer is preferably 0.5 to 25 mm in thickness, more preferably 1 to 10 mm in thickness, most preferably 2 to 7 mm in thickness.
- the inner layer 6 may be in different designs, but should provide sufficient breathability that the patient does not excessively sweat while wearing the cranial cap dressing 2 .
- the skin 16 facing proximal surface 18 of the inner layer 6 preferably has a polyester wound contact film polymer 20 , similar to TelfaTM “Ouchless” Non-Adherent Dressings, that contacts the patient's skin 16 but helps prevent the inner layer 6 from sticking to the patient's skin 16 .
- the layer of contact film polymer 20 would allow the inner layer 6 to provide abortion of body fluids without substantially sticking to the patient's skin 16 or hair.
- the contact film polymer 20 would preferably have sufficient perforations 22 , such as 382 holes per square inch, with each hole having a diameter of 0.020-0.030 inch, to allow moist vapor transmission and fluid transmission into the inner absorbent core 24 of the bandage 14 of the inner layer 6 —between the contact film polymer 20 and the outer layer 2 .
- the skin 16 facing proximal surface of the contact film polymer 20 is preferably impregnated with elemental or preferably ionic silver 26 to help promote wound healing without infection, in the form of silver nitrate or silver sulfadiazine, for example.
- the proximal surface 18 of the inner layer would preferably be impregnated with elemental or preferably ionic silver 26 to help promote wound healing without infection.
- Another anti-microbial agent 26 may be used in addition to or in place of the silver 26 .
- the silver 26 may be dispersed in the absorbent core 24 of the bandage 14 of the inner layer 6 to reduce bacterial growth in the absorbent core 24
- the inner layer 6 is formed as a checkered pattern of gauze 14 lining the proximal surface 28 of the outer layer 4 , with gaps or preferably unobstructed breathing channels 30 between adjacent gauze pads 14 .
- the breathing channels 30 facilitate the vapor passage 10 or passage of humid air and heat from the skin 16 of the patient between the inner layer gauze pads 14 , through the outer layer 4 .
- the distal surface 32 (facing away from the patient) of the inner layer 6 here the gauze pads 14 , would be affixed, preferably mechanically or chemically, to the proximal surface 28 of the outer layer 28 .
- the inner layer 6 could be a continuous layer of absorbent fabric or material 14 with perforations through the material to provide breathing channels 30 .
- breathing channels 30 are preferred, if the inner layer 6 material is itself sufficiently breathable, the distinct breathing channels 30 may be omitted.
- the inner layer 6 could be non-elastic, or could have an elastic element 34 integrated or woven within the inner layer 6 .
- the elastic element could be integrated throughout the inner layer 6 , or in just specific locations, like in the breathing channels 30 , for example.
- the elastic elements 34 could include a plurality of single spandex micro-fiber strands.
- a proximal stretchable breathable layer 36 could line the proximal surface 18 of the inner layer 6 , shown partially in FIG. 5 .
- the cranial cap dressing 2 would have an absorbent inner layer 6 sandwiched between two stretchable breathable layers 4 , 36 .
- the proximal breathable layer 36 may have a perforated contact film polymer lining 20 on the proximal surface which contacts the patient's skin, to help prevent sticking to the wound, skin, or hair, which may also be impregnated or lined with anti-microbial agent 26 .
- the cap would provide circumferential coverage over a cranium 38 to allow coverage of a craniotomy incision 40 at basically any location. Shown in FIGS. 1 and 2 is a typical incision site for a temporal craniotomy, but the cap is designed to be used for dressing incisions of various craniotomies.
- craniotomies include, for example, the pterional and frontotemporal craniotomy incisions, which normally extend from the zygomatic arch 1 cm in front of the tragus, curves anteriorly, remains behind the hairline, and ends at widow's peak; the frontal craniotomy (unilateral or bilateral) incisions, in which unilateral approach uses an incision starting less than 1 cm anterior to the tragus and just above the zygomatic arch, curves superiorly and posteriorly, and ends at the midline frontally and the bilateral approach uses an ear-to-ear incision (also known as a bicoronal incision) that is also less than 1 cm anterior to the tragus and terminates on each side just above the zygomatic arches while remaining behind the hairline; the temporal craniotomy incisions (shown), which may be linear or question-mark depending on the target pathology, where linear incisions normally stay within the temporalis muscle and begin anterior to the tragus, 1-2 cm above the zy
- the inner layer 6 may have a greater average and/or maximum thickness 52 in an area of the cranial cap dressing 2 that overlaps or corresponds to an area of a typical incision for common craniotomies, including those listed above, than an average and/or maximum thickness in areas not overlapping not corresponding with the specific craniotomy.
- the cranial cap dressing 2 shown in FIG. 6 is for a question mark temporal craniotomy. Separate cranial cap dressings 2 could be available for the different common craniotomies in the different cranial cap dressing 2 sizes.
- the amount of overlap could vary, but would preferably be extend between 0.5 to 4 inches from either side of a typical incision 40 , more preferably from 1 to 3 inches from either side of a typical incision 40 , and most preferably from 1.5 to 2 inches from either side of a typical incision 40 .
- the greater thickness 52 of the inner layer would preferably be from a relatively greater thickness 52 of bandage portion 14 of inner layer 6 around the area of the typical incision 40 than other areas of the cranial cap dressing 2 .
- the relatively greater thickness 52 can be from extra thickness of the bandage portion 14 in the area of the typical incision 40 , or from a normal thickness of the bandage portion 14 in the area of the typical incision 40 and a reduced or no thickness of the bandage portion 14 of the other areas of the cranial cap dressing 2 .
- the relatively greater thickness 52 can allow for bandages 14 to adsorb any fluid from the incision/wound 12 , 34 .
- the relatively greater thickness will facilitate a relatively greater pressure being applied by the cranial cap dressing 2 at the wound location and simultaneously allow for increased heat and vapor transmission, increased comfort, and reduced pressure being applied in other areas cranial cap dressing 2 not associated with the incision 40 .
- the bandage portion 14 of the cranial cap dressing 2 may initially extend substantially continuously in the cranial cap dressing 2 , but may be perforated or otherwise pre-cut and preferably marked in multiple designs.
- the pre-cut/marked portions will preferably correspond to the areas of the typical incisions 40 for common craniotomies.
- a single cranial cap dressing 2 may be provided for multiple craniotomies, and then the surgeon could simply and easily remove the excess bandages from the bandage portion 14 , and leave the bandage portion 14 that corresponds to the specific craniotomy incision 40 that the surgeon is performing on the patient.
- the cranial cap dressing 2 extends below the ears and down below the inion to the base of the neck.
- a string tie or other mechanical fastener 42 is preferably present as an extra security measure to help insure the cranial cap dressing 2 stays in place.
- a string 44 for example being continuous with the string tie 42 , may extend in a channel 46 around the circumference 48 of the cranial cap dressing 2 , with free ends extending out of opening 50 in the channel 46 at the posterior inferior terminus of the cranial cap dressing 2 .
- the knotted string tie 42 portion could be left open, could be covered by a flap or it could fit in to a pocket on the interior or exterior of the cranial cap dressing 2 .
- the string 44 could also just extend a portion of the way from the opening 50 into the channels 46 , and not the full circumference 48 of the cranial cap dressing 2 . Additionally, the string 44 and the mechanical fastener 42 at the posterior inferior terminus of the cranial cap dressing 2 may be discontinuous with one another.
- the string 44 is preferably substantially non-elastic.
- the placement of the string tie 42 is to minimize obstruction and maximize chances that a patient having an altered mental state will not bother it.
- Other extra security measure attachments could be used in addition or in place of the string 44 and/or string tie 42 , including a Velcro flap, buttons, snaps, latches, buckles, or fabric ties, for example. There could be more than one extra security measure attachment, though one is preferred for ease of use.
- the string tie 42 or other extra security measure attachment could be placed at other locations, but the posterior inferior terminus of the cranial cap dressing 2 is preferred. Additionally, or alternatively to the string 44 , another circumferential reinforcement could be provided along a portion of the circumference 48 of the cranial cap dressing 2 . The portion being preferably a majority of the circumference 48 of the cranial cap dressing 2 , and most preferably substantially the entire circumference 48 of the cranial cap dressing 2 .
- the cranial cap dressing 2 may have one or more flaps 53 that could be folded down to cover incisions 40 that extend below the circumference 48 or inferior edge of the cranial cap dressing 2 .
- the cranial cap dressing 2 may also be rolled up from the back for comfort if the incision site 40 was in another location.
- substantially the entire outer layer 4 has a uniform elasticity
- different areas of the outer layer 4 may be of different elasticities, with, for example, an area around the incision 40 having a greater elasticity than other areas of the cranial cap dressing 2 .
- a distal surface 54 (facing away from patient) of the outer layer 4 has a low coefficient of static friction to minimize the interaction between the cranial cap dressing 2 and a patient's sheets, pillowcases, and bed coverings, thus reducing relative movement of the cranial cap dressing 2 and the patient's skin 16 —preferably with a coefficient of static friction between two pieces of the same material being less than 0.3, more preferably being less than 0.2, and most preferably being less than 0.1.
- a removable medical adhesive or gel 56 is attached to the circumference 48 of the cranial cap dressing 2 , to help the cranial cap dressing 2 maintain its coverage over the head 8 of the patient.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Otolaryngology (AREA)
- Materials For Medical Uses (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
Abstract
Description
- This application is a continuation of U.S. patent application Ser. No. 15/192,002 filed Jun. 24, 2016 which claims priority from U.S. Provisional Patent Application No. 62/185,933 filed Jun. 29, 2015, which is incorporated by reference into the present disclosure as if fully restated herein. To the extent that there is any conflict between the incorporated material and the present disclosure, the present disclosure will control.
- The present invention relates generally to surgical dressing and specifically to a cranial cap dressing.
- Long-term placement of a sterile dressing after a craniotomy can be difficult to manage. Completely shaving the patient's hair can be traumatic to the patient. Therefore, to maintain comesis, minimal hair shaving is practiced by neurosurgeons. As a consequence of minimal hair shaving though, adhesive dressings cannot stay secured to the incision site without the use of mechanical attachment such as staples. However, the use of staples is not preferred by many surgeons and patients. An alternative to adhesive dressing is the use linear wrap bandages, such as ACE® wrap elastic bandage and/or Kerlix® gauze wrap bandages to wrap the head. One problem with the linear wrap bandages is that they can be easily removed by the patient if the patient has an altered mental status and/or is unable to follow and/or remember simple instructions. Many times patients having altered mental status will pick at the wound site dressing if not covered. A second problem with the linear wrap bandages is that when a patient lies down on his bed and moves his head with relation to the pillow, the linear wrap bandage will many times roll up, exposing previously covered skin. These problems can expose patients to wound infections, thus leading to longer hospital stays, more surgical interventions, and higher costs of medical care.
- Wherefore, it is an object of the present invention to overcome the above mentioned shortcomings and drawbacks associated with the prior art.
- Another object of the present invention is to provide a sterile cranial cap dressing with draw strings to provide a sterile barrier over the surgical site.
- A further object of the present invention is to reduce the infection rate post craniotomy.
- Yet another object of the present invention is to secure placement of craniotomy surgical dressing.
- A still further object of the present invention is to increase the speed and accuracy in which craniotomy surgical dressing is applied.
- The present invention also relates to a cranial cap dressing for dressing a craniotomy wound comprising a breathable elastic outer layer sized to fit snuggly on a human head of a patient and an absorbent inner layer attached to the breathable elastic outer layer.
- The present invention relates to methods of dressing a craniotomy and cranial cap dressings for dressing a human craniotomy wound comprising a breathable elastic outer layer sized to fit snuggly on a head of a human patient, and an absorbent inner layer attached to the breathable elastic outer layer.
- An optional further embodiment includes a plurality of breathing channels in the absorbent inner layer providing a passageway for air through the absorbent inner layer to the breathable elastic outer layer.
- An optional further embodiment includes a contact film polymer layer coating on a proximal skin facing surface of the inner layer that reduces the adhesion of the inner layer to the wound. An optional further embodiment includes a plurality of perforations in the contact film polymer layer coating to allow air and bodily fluids to pass through the contact film polymer layer coating.
- An optional further embodiment includes a mechanical fastener along a circumference of the cranial cap dressing, which helps secure the cranial cap dressing on the head of the patient. An optional further embodiment includes the mechanical fastener being one of a Velcro flap, a button, a snap, a latch, a buckle, a fabric tie, and a string tie. An optional further embodiment includes the mechanical fastener being located at an inferior posterior most portion of the cranial cap dressing. An optional further embodiment includes the mechanical fastener being a string tie and further comprising a string substantially further comprising a substantially non-elastic string extending in a channel around the circumference of the cranial cap dressing.
- An optional further embodiment includes an anti-microbial agent being affixed to a proximal surface of the inner layer. An optional further embodiment includes the antimicrobial agent being one of elemental or ionic silver. An optional further embodiment includes the antimicrobial agent being one of silver nitrate and silver sulfadiazine.
- An optional further embodiment includes the breathable elastic outer layer having a coefficient of static friction between two pieces of the same material being less than 0.3.
- An optional further embodiment includes a proximate breathable layer attached to the inner layer, opposite to the outer layer.
- An optional further embodiment includes a maximum thickness of the inner layer being greater in an area corresponding to an incision than a maximum thickness of the inner layer in an area spaced from the area corresponding to the incision.
- An optional further embodiment includes the inner layer being formed as a checkered pattern of absorbent material lining a proximal skin facing surface of the outer layer.
- An optional further embodiment includes the inner layer being a substantially a continuous layer of absorbent material extending substantially completely across a proximal skin facing surface of the outer layer. An optional further embodiment includes a plurality of perforations through the inner layer to provide breathing channels for vapor to pass through the inner layer to the outer layer.
- An optional further embodiment includes a medical adhesive or gel affixed to a circumference of the cranial cap dressing to help releasably secure the cranial cap dressing to a skin of the patient.
- An optional further embodiment includes the cranial cap dressing substantially completely covering a cranium of the patient.
- An optional further embodiment includes one or more flap that may be folded down to cover incisions that extend below a circumference of the cranial cap dressing.
- The accompanying drawings, which are incorporated in and constitute a part of the specification, illustrate various embodiments of the invention and together with the general description of the invention given above and the detailed description of the drawings given below, serve to explain the principles of the invention. It is to be appreciated that the accompanying drawings are not necessarily to scale since the emphasis is instead placed on illustrating the principles of the invention. The invention will now be described, by way of example, with reference to the accompanying drawings in which:
-
FIG. 1 is a drawing of a human patient with the cranium location indicated; -
FIG. 2 is a diagrammatic representation of the cranial cap dressing according to the present invention, with the cranial cap dressing represented as hatched lines to allow context of the cranial cap dressing's placement; -
FIG. 3 is a diagrammatic representation of the inner lining of a first embodiment of the cranial cap dressing ofFIG. 2 in the area indicated F3/F4; -
FIG. 4 is a diagrammatic representation of the inner lining of a second embodiment of the cranial cap dressing analogous with the area indicated F3/F4 inFIG. 2 ; -
FIG. 5 is a diagrammatic representation of a cross section ofFIG. 3 along the view indicated as F5; and -
FIG. 6 is a diagrammatic representation of a further embodiment of the cranial cap dressing according to the present invention, with the cranial cap dressing represented as hatched lines to allow context of the cranial cap dressing's placement. - The present invention will be understood by reference to the following detailed description, which should be read in conjunction with the appended drawings. It is to be appreciated that the following detailed description of various embodiments is by way of example only and is not meant to limit, in any way, the scope of the present invention. In the summary above, in the following detailed description, in the claims below, and in the accompanying drawings, reference is made to particular features (including method steps) of the present invention. It is to be understood that the disclosure of the invention in this specification includes all possible combinations of such particular features, not just those explicitly described. For example, where a particular feature is disclosed in the context of a particular aspect or embodiment of the invention or a particular claim, that feature can also be used, to the extent possible, in combination with and/or in the context of other particular aspects and embodiments of the invention, and in the invention generally. The term “comprises” and grammatical equivalents thereof are used herein to mean that other components, ingredients, steps, etc. are optionally present. For example, an article “comprising” (or “which comprises”) components A, B, and C can consist of (i.e., contain only) components A, B, and C, or can contain not only components A, B, and C but also one or more other components. Where reference is made herein to a method comprising two or more defined steps, the defined steps can be carried out in any order or simultaneously (except where the context excludes that possibility), and the method can include one or more other steps which are carried out before any of the defined steps, between two of the defined steps, or after all the defined steps (except where the context excludes that possibility).
- The term “at least” followed by a number is used herein to denote the start of a range beginning with that number (which may be a range having an upper limit or no upper limit, depending on the variable being defined). For example “at least 1” means 1 or more than 1. The term “at most” followed by a number is used herein to denote the end of a range ending with that number (which may be a range having 1 or 0 as its lower limit, or a range having no lower limit, depending upon the variable being defined). For example, “at most 4” means 4 or less than 4, and “at most 40% means 40% or less than 40%. When, in this specification, a range is given as “(a first number) to (a second number)” or “(a first number)-(a second number),” this means a range whose lower limit is the first number and whose upper limit is the second number. For example, 25 to 100 mm means a range whose lower limit is 25 mm, and whose upper limit is 100 mm. The embodiments set forth the below represent the necessary information to enable those skilled in the art to practice the invention and illustrate the best mode of practicing the invention. In addition, the invention does not require that all the advantageous features and all the advantages need to be incorporated into every embodiment of the invention.
- Turning now to
FIGS. 1-5 , a brief description concerning the various components of the present invention will now be briefly discussed. As can be seen in this embodiment, the cranial cap dressing 2 comprises and anouter layer 4 and aninner layer 6. Theouter layer 6 is preferably stretchable and breathable and allows application of the cranial cap dressing 2 to at least a variety ofhead 8 sizes for different patients. Theouter layer 4 can be comprised of normal and/or microfiber designs of synthetic and/or natural fiber alone or in a blend with each other and/or an additional elastic fiberelastic element 34. The synthetic fibers include polyester, nylon, rayon, acetate, ingeo, lyocell, olefin, and polylactide, for example. The natural fibers include cotton and flax, for example. The elastic fibers can include spandex, for example. Theouter layer 4 material should be porous enough to provide breathability orready vapor passage 10 to avoid excessive sweating while wearing thecranial cap dressing 2. Excessive sweat can lead to periwound maceration among other issues. - The
outer layer 4, while preferably elastic, is not meant to apply physiologically significant compressive force on the patient'shead 8, which would be counterproductive forwound 12 healing. The elasticity is meant to be sufficient to fit a variety ofhead 8 sizes and to snuggly fit onto a patient'shead 8 and remain in place without any additional binding. It is anticipated that four sizes ofcranial cap dressings 2 will be sufficient for most of the population, from smallest to largest: being pediatric, teen, small adult, large adult. Theouter layer 4 is designed to preferably not restrict or cut off blood circulation to the patient'shead 8. Theouter layer 4 is physical barrier protecting thewound 12 from the patient purposely or inadvertently picking at or disturbing thewound site 12. Theouter layer 4 also provides scaffolding for theinner layer 6bandage 14, holding theinner layer 6 in place on thesurface 16 of the patient'shead 8. Theouter layer 4 can be of uniform elasticity and thickness, or it could have increased elasticity and/or thickness especially adjacent to the perimeter edges of the cranial cap dressing 2, to increase the chances that the cranial cap dressing 2 will stay in place as the patient moves in bed. - The
inner layer 6 would be preferably comprised of an adsorbent material that allows for fluid absorption, such as blood, sweat and other body fluids, keeping theskin 16 andsurgical site 12 appropriately dry. Theinner layer 4 material may be cotton or cotton based, or other natural or synthetic adsorbent material. The inner layer is preferably 0.5 to 25 mm in thickness, more preferably 1 to 10 mm in thickness, most preferably 2 to 7 mm in thickness. Theinner layer 6 may be in different designs, but should provide sufficient breathability that the patient does not excessively sweat while wearing thecranial cap dressing 2. - The
skin 16 facing proximal surface 18 of theinner layer 6 preferably has a polyester wound contact film polymer 20, similar to Telfa™ “Ouchless” Non-Adherent Dressings, that contacts the patient'sskin 16 but helps prevent theinner layer 6 from sticking to the patient'sskin 16. The layer of contact film polymer 20 would allow theinner layer 6 to provide abortion of body fluids without substantially sticking to the patient'sskin 16 or hair. The contact film polymer 20 would preferably havesufficient perforations 22, such as 382 holes per square inch, with each hole having a diameter of 0.020-0.030 inch, to allow moist vapor transmission and fluid transmission into the innerabsorbent core 24 of thebandage 14 of theinner layer 6—between the contact film polymer 20 and theouter layer 2. Theskin 16 facing proximal surface of the contact film polymer 20 is preferably impregnated with elemental or preferablyionic silver 26 to help promote wound healing without infection, in the form of silver nitrate or silver sulfadiazine, for example. If no contact film polymer 20 is used, the proximal surface 18 of the inner layer would preferably be impregnated with elemental or preferablyionic silver 26 to help promote wound healing without infection. Anotheranti-microbial agent 26 may be used in addition to or in place of thesilver 26. Additionally, thesilver 26 may be dispersed in theabsorbent core 24 of thebandage 14 of theinner layer 6 to reduce bacterial growth in theabsorbent core 24 - In a first embodiment, as shown in
FIG. 3 , theinner layer 6 is formed as a checkered pattern ofgauze 14 lining theproximal surface 28 of theouter layer 4, with gaps or preferablyunobstructed breathing channels 30 betweenadjacent gauze pads 14. Thebreathing channels 30 facilitate thevapor passage 10 or passage of humid air and heat from theskin 16 of the patient between the innerlayer gauze pads 14, through theouter layer 4. The distal surface 32 (facing away from the patient) of theinner layer 6, here thegauze pads 14, would be affixed, preferably mechanically or chemically, to theproximal surface 28 of theouter layer 28. - Alternatively or additionally, as shown in
FIG. 4 , theinner layer 6 could be a continuous layer of absorbent fabric ormaterial 14 with perforations through the material to providebreathing channels 30. Though breathingchannels 30 are preferred, if theinner layer 6 material is itself sufficiently breathable, thedistinct breathing channels 30 may be omitted. - The
inner layer 6 could be non-elastic, or could have anelastic element 34 integrated or woven within theinner layer 6. The elastic element could be integrated throughout theinner layer 6, or in just specific locations, like in thebreathing channels 30, for example. Theelastic elements 34 could include a plurality of single spandex micro-fiber strands. - Additionally, a proximal stretchable
breathable layer 36, similar to theouter layer 4 material, could line the proximal surface 18 of theinner layer 6, shown partially inFIG. 5 . In this embodiment the cranial cap dressing 2 would have an absorbentinner layer 6 sandwiched between two stretchablebreathable layers breathable layer 36 may have a perforated contact film polymer lining 20 on the proximal surface which contacts the patient's skin, to help prevent sticking to the wound, skin, or hair, which may also be impregnated or lined withanti-microbial agent 26. - Turning again to
FIG. 1 , the cap would provide circumferential coverage over acranium 38 to allow coverage of acraniotomy incision 40 at basically any location. Shown inFIGS. 1 and 2 is a typical incision site for a temporal craniotomy, but the cap is designed to be used for dressing incisions of various craniotomies. These various craniotomies include, for example, the pterional and frontotemporal craniotomy incisions, which normally extend from the zygomatic arch 1 cm in front of the tragus, curves anteriorly, remains behind the hairline, and ends at widow's peak; the frontal craniotomy (unilateral or bilateral) incisions, in which unilateral approach uses an incision starting less than 1 cm anterior to the tragus and just above the zygomatic arch, curves superiorly and posteriorly, and ends at the midline frontally and the bilateral approach uses an ear-to-ear incision (also known as a bicoronal incision) that is also less than 1 cm anterior to the tragus and terminates on each side just above the zygomatic arches while remaining behind the hairline; the temporal craniotomy incisions (shown), which may be linear or question-mark depending on the target pathology, where linear incisions normally stay within the temporalis muscle and begin anterior to the tragus, 1-2 cm above the zygomatic arch, and extend anywhere from 6-8 cm above the arch; question-mark incisions also run anterior to the tragus, begin just above the zygomatic arch, and curve posteriorly at the top of the pinna 6-9 cm, then superiorly to the superior temporal line, then anteriorly toward the forehead, terminating at the hairline; and the suboccipital craniotomy/craniectomy incisions, which involve a few incision types, including midline and paramedian incisions that are linear, midline incision extends from 6 cm above the inion to the C2 spinous process; paramedian incision (also referred to as a retrosigmoid approach) begins 5 mm medial to the mastoid notch and extends 4-6 cm above and below the notch, “hockey-stick” incisions are curved and begin in the midline at the C2 spinous process, extend superiorly to just above the inion, and then laterally to mastoid tip with a terminal caudal curve. - In further embodiments, the
inner layer 6 may have a greater average and/ormaximum thickness 52 in an area of the cranial cap dressing 2 that overlaps or corresponds to an area of a typical incision for common craniotomies, including those listed above, than an average and/or maximum thickness in areas not overlapping not corresponding with the specific craniotomy. For example, the cranial cap dressing 2 shown inFIG. 6 is for a question mark temporal craniotomy. Separatecranial cap dressings 2 could be available for the different common craniotomies in the different cranial cap dressing 2 sizes. The amount of overlap could vary, but would preferably be extend between 0.5 to 4 inches from either side of atypical incision 40, more preferably from 1 to 3 inches from either side of atypical incision 40, and most preferably from 1.5 to 2 inches from either side of atypical incision 40. Thegreater thickness 52 of the inner layer would preferably be from a relativelygreater thickness 52 ofbandage portion 14 ofinner layer 6 around the area of thetypical incision 40 than other areas of thecranial cap dressing 2. The relativelygreater thickness 52 can be from extra thickness of thebandage portion 14 in the area of thetypical incision 40, or from a normal thickness of thebandage portion 14 in the area of thetypical incision 40 and a reduced or no thickness of thebandage portion 14 of the other areas of thecranial cap dressing 2. The relativelygreater thickness 52 can allow forbandages 14 to adsorb any fluid from the incision/wound 12, 34. The relatively greater thickness will facilitate a relatively greater pressure being applied by the cranial cap dressing 2 at the wound location and simultaneously allow for increased heat and vapor transmission, increased comfort, and reduced pressure being applied in other areas cranial cap dressing 2 not associated with theincision 40. - In a variation of this embodiment, the
bandage portion 14 of the cranial cap dressing 2 may initially extend substantially continuously in the cranial cap dressing 2, but may be perforated or otherwise pre-cut and preferably marked in multiple designs. The pre-cut/marked portions will preferably correspond to the areas of thetypical incisions 40 for common craniotomies. In this way, a single cranial cap dressing 2 may be provided for multiple craniotomies, and then the surgeon could simply and easily remove the excess bandages from thebandage portion 14, and leave thebandage portion 14 that corresponds to thespecific craniotomy incision 40 that the surgeon is performing on the patient. - As shown in
FIG. 2 , the cranial cap dressing 2 extends below the ears and down below the inion to the base of the neck. A string tie or othermechanical fastener 42 is preferably present as an extra security measure to help insure the cranial cap dressing 2 stays in place. A string 44, for example being continuous with thestring tie 42, may extend in a channel 46 around thecircumference 48 of the cranial cap dressing 2, with free ends extending out of opening 50 in the channel 46 at the posterior inferior terminus of thecranial cap dressing 2. The knottedstring tie 42 portion could be left open, could be covered by a flap or it could fit in to a pocket on the interior or exterior of thecranial cap dressing 2. The string 44 could also just extend a portion of the way from theopening 50 into the channels 46, and not thefull circumference 48 of thecranial cap dressing 2. Additionally, the string 44 and themechanical fastener 42 at the posterior inferior terminus of the cranial cap dressing 2 may be discontinuous with one another. The string 44 is preferably substantially non-elastic. The placement of thestring tie 42 is to minimize obstruction and maximize chances that a patient having an altered mental state will not bother it. Other extra security measure attachments could be used in addition or in place of the string 44 and/orstring tie 42, including a Velcro flap, buttons, snaps, latches, buckles, or fabric ties, for example. There could be more than one extra security measure attachment, though one is preferred for ease of use. Thestring tie 42 or other extra security measure attachment could be placed at other locations, but the posterior inferior terminus of the cranial cap dressing 2 is preferred. Additionally, or alternatively to the string 44, another circumferential reinforcement could be provided along a portion of thecircumference 48 of thecranial cap dressing 2. The portion being preferably a majority of thecircumference 48 of the cranial cap dressing 2, and most preferably substantially theentire circumference 48 of thecranial cap dressing 2. - The cranial cap dressing 2 may have one or
more flaps 53 that could be folded down to coverincisions 40 that extend below thecircumference 48 or inferior edge of thecranial cap dressing 2. The cranial cap dressing 2 may also be rolled up from the back for comfort if theincision site 40 was in another location. - While in the preferred embodiment, substantially the entire
outer layer 4 has a uniform elasticity, in further embodiments different areas of theouter layer 4 may be of different elasticities, with, for example, an area around theincision 40 having a greater elasticity than other areas of thecranial cap dressing 2. In yet further embodiments, a distal surface 54 (facing away from patient) of theouter layer 4 has a low coefficient of static friction to minimize the interaction between the cranial cap dressing 2 and a patient's sheets, pillowcases, and bed coverings, thus reducing relative movement of the cranial cap dressing 2 and the patient'sskin 16—preferably with a coefficient of static friction between two pieces of the same material being less than 0.3, more preferably being less than 0.2, and most preferably being less than 0.1. In yet further embodiments, a removable medical adhesive orgel 56 is attached to thecircumference 48 of the cranial cap dressing 2, to help the cranial cap dressing 2 maintain its coverage over thehead 8 of the patient. - The invention illustratively disclosed herein suitably may explicitly be practiced in the absence of any element which is not specifically disclosed herein. While various embodiments of the present invention have been described in detail, it is apparent that various modifications and alterations of those embodiments will occur to and be readily apparent those skilled in the art. However, it is to be expressly understood that such modifications and alterations are within the scope and spirit of the present invention, as set forth in the appended claims. Further, the invention(s) described herein is capable of other embodiments and of being practiced or of being carried out in various other related ways. In addition, it is to be understood that the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting. The use of “including,” “comprising,” or “having” and variations thereof herein is meant to encompass the items listed thereafter and equivalents thereof as well as additional items while only the terms “consisting of” and “consisting only of” are to be construed in the limitative sense.
Claims (21)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/798,707 US20200222245A1 (en) | 2015-06-29 | 2020-02-24 | Cranial cap dressing |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562185933P | 2015-06-29 | 2015-06-29 | |
US15/192,002 US10603220B2 (en) | 2015-06-29 | 2016-06-24 | Cranial cap dressing |
US16/798,707 US20200222245A1 (en) | 2015-06-29 | 2020-02-24 | Cranial cap dressing |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/192,002 Division US10603220B2 (en) | 2015-06-29 | 2016-06-24 | Cranial cap dressing |
Publications (1)
Publication Number | Publication Date |
---|---|
US20200222245A1 true US20200222245A1 (en) | 2020-07-16 |
Family
ID=57601431
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/192,002 Active 2038-04-01 US10603220B2 (en) | 2015-06-29 | 2016-06-24 | Cranial cap dressing |
US16/798,707 Abandoned US20200222245A1 (en) | 2015-06-29 | 2020-02-24 | Cranial cap dressing |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/192,002 Active 2038-04-01 US10603220B2 (en) | 2015-06-29 | 2016-06-24 | Cranial cap dressing |
Country Status (1)
Country | Link |
---|---|
US (2) | US10603220B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20220150611A (en) * | 2021-05-04 | 2022-11-11 | 성광메디텍 주식회사 | Dressing cap |
WO2023248184A1 (en) * | 2022-06-22 | 2023-12-28 | Mor Research Applications Ltd. | Devices, systems and methods for protecting the brain in craniectomy patients |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110368191A (en) * | 2019-04-09 | 2019-10-25 | 中国人民解放军联勤保障部队第九二0医院 | A kind of collapsible protectiveness binding device exposed for brain tissue |
EP4021233A4 (en) * | 2019-09-20 | 2024-02-21 | Create To Overcome Llc | Multilayer garments worn during wound care |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB763721A (en) * | 1951-03-27 | 1956-12-19 | Theodore Oscar Wegner | Improvements in and relating to skull caps |
US2726398A (en) * | 1952-02-01 | 1955-12-13 | Us Rubber Co | Bathing caps |
US3370304A (en) * | 1965-06-25 | 1968-02-27 | Pelletier Eugene | Hair-protecting head covering |
US3512181A (en) * | 1968-01-19 | 1970-05-19 | Marvin J Osborne | Disposable cap |
US4279039A (en) * | 1979-06-25 | 1981-07-21 | American Aquatic Concepts And Enterprises, Inc. | Swim cap with integral eye protection |
USD295446S (en) * | 1984-11-21 | 1988-04-26 | Malte Lundell | Head bandage protector |
US4937885A (en) * | 1988-12-27 | 1990-07-03 | Gregg Robert F | Head covering |
US5031609A (en) * | 1990-04-06 | 1991-07-16 | Fye Letty A | Postoperative compression bandage for the head |
US5571079A (en) * | 1994-12-30 | 1996-11-05 | Algos Pharmaceutical Corporation | Wound dressing |
US6664434B2 (en) * | 2000-05-23 | 2003-12-16 | John C. Cominsky | Medical device for containing body fluids |
US20050262617A1 (en) * | 2004-05-28 | 2005-12-01 | Andrew Szypka | Absorbent cranial cap |
EP1924231A2 (en) * | 2005-08-31 | 2008-05-28 | Coloplast A/S | Layered product with adhesive dressing for non-touch application |
US8262601B2 (en) * | 2008-06-02 | 2012-09-11 | Michelle Cumming | Helmet trauma bandage and method |
US7887501B2 (en) * | 2008-06-02 | 2011-02-15 | Riordan John P | Compressive head dressings and associated methods |
US9149393B2 (en) * | 2008-06-02 | 2015-10-06 | First Responder Solutions, Llc | Head trauma bandage cap and method |
-
2016
- 2016-06-24 US US15/192,002 patent/US10603220B2/en active Active
-
2020
- 2020-02-24 US US16/798,707 patent/US20200222245A1/en not_active Abandoned
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20220150611A (en) * | 2021-05-04 | 2022-11-11 | 성광메디텍 주식회사 | Dressing cap |
KR102499844B1 (en) | 2021-05-04 | 2023-02-16 | 성광메디텍 주식회사 | Dressing cap |
WO2023248184A1 (en) * | 2022-06-22 | 2023-12-28 | Mor Research Applications Ltd. | Devices, systems and methods for protecting the brain in craniectomy patients |
IL294216A (en) * | 2022-06-22 | 2024-01-01 | Mor Research Applic Ltd | Devices, systems and methods for protecting the brain in craniectomy patients |
Also Published As
Publication number | Publication date |
---|---|
US10603220B2 (en) | 2020-03-31 |
US20160374864A1 (en) | 2016-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200222245A1 (en) | Cranial cap dressing | |
US11432965B2 (en) | Medical bandage for the head, a limb or a stump | |
US9867965B1 (en) | Medical bandage for the head, a limb or a stump | |
US9149393B2 (en) | Head trauma bandage cap and method | |
JP4271513B2 (en) | Adhesive bandage | |
US7022891B2 (en) | Dressing and an epidermal positioning mechanism and method for using same | |
US6982359B1 (en) | Nasal epidermal lifting mechanism | |
US20190298882A1 (en) | Hydrogel bandage | |
US10376417B2 (en) | Head trauma bandage cap and method | |
US10993843B2 (en) | Head trauma bandage cap and method | |
JP2004130079A5 (en) | ||
US7780615B1 (en) | Anatomically designed, reusable secondary wound wrap for a digit | |
US6768039B1 (en) | Nasal epidermal lifting mechanism | |
US20200000644A1 (en) | Head trauma bandage cap and method | |
US20190029886A1 (en) | Wound therapy apparatus with scar modulation properties and related methods | |
US10792193B2 (en) | Nasal drip pad | |
US10022274B1 (en) | Systems and methods for wound healing | |
US20210244573A1 (en) | Head trauma bandage cap | |
US11766074B1 (en) | Therapeutic sock | |
CA2515601C (en) | Nasal epidermal lifting mechanism | |
AU763792B2 (en) | Nasal epidermal lifting mechanism | |
WO2018208564A1 (en) | Head trauma bandage cap and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE, LOUISIANA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AHMED, OSAMA;REEL/FRAME:052132/0932 Effective date: 20141017 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: PRE-INTERVIEW COMMUNICATION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |